ANI Pharmaceuticals Inc

ANIP

Company Profile

  • Business description

    ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid dose products. Its areas of product development include narcotics, oncolytic, hormones and steroids, and complex formulations involving extended release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.

  • Contact

    210 Main Street West
    BaudetteMN56623
    USA

    T: +1 218 634-3500

    E: [email protected]

    https://www.anipharmaceuticals.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 December 2025

    Employees

    642

Stocks News & Analysis

stocks

Vote in favour of merger for undervalued ASX share

We recommend shareholders vote in favor of its proposed merger.
stocks

Are investors missing the boat on this future ASX leader?

The market is underestimating the clear path to profitability.
stocks

ASX shares plunge but remain undervalued

Shares drop 17% after guidance is revised but we still see value.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,569.10112.301.33%
CAC 407,623.38148.791.99%
DAX 4020,611.4136.730.18%
Dow JONES (US)43,221.55703.271.65%
FTSE 1008,359.1958.060.70%
HKSE19,522.89236.821.23%
NASDAQ19,511.23466.842.45%
Nikkei 22538,572.60128.020.33%
NZX 50 Index13,000.6757.100.44%
S&P 5005,949.91107.001.83%
S&P/ASX 2008,327.00113.701.38%
SSE Composite Index3,236.038.920.28%

Market Movers